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Abstract In the treatment of lifestyle diseases, including
metabolic syndrome and type 2 diabetes, it is important to
lower body mass and fat tissue, and consequently, to increase
insulin-sensitivity. Unfortunately, it often happens that low-
energy diet which would lower overweight is not observed
and, thus, it does not bring the expected effects. This paper
discusses the influence of three diets—control, high-fructose,
and high-fatty diet—on absorption of energy from food in
order to transform it into body mass. The kJ/g ratio which
describes this process has been calculated. In the tested diets,
the addition of fructose (79.13±2.47 kJ/g) or fat (82.48±
2.28 kJ/g) results in higher transformation of energy into body
mass than in the case of control diet (89.60±1.86 kJ/g). The
addition of Na[VO(O2)2(4,4′-Me2-2,2′-bpy)]•8H2O (where
4,4′-Me2-2,2′-bpy=4,4′-dimethyl-2,2′-bipyridine) results in sta-
tistical increase of that ratio: fructose diet (86.88±0.44 kJ/g), fat
diet (104.68±3.01 kJ/g), and control diet (115.98±0.56 kJ/g),
respectively. Fat diet statistically influences the decrease of
kidney mass in comparison to the other diets. The application
of the tested vanadium compound results also in the statistical
decrease of the fatty liver caused by fructose and fat diet.
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Introduction
Diabetes, cardiovascular disease, obesity, and depression are
among the most frequently diagnosed civilization diseases
[1–3]. The root of these diseases is improper diet and meta-
bolic changes in the organism, associated with low physical
activity. It is mainly the consumption of high monosaccha-
rides, simple sugars, and high saturated fat acids combined
with low physical activity that can provoke the
abovementioned illnesses [4–6]. High processed food is likely
to be important in this process. For this reason, currently,
many dietary methods (diets) are used in prevention of these
risks [7–9]. Frequently, nutritional regime is difficult to main-
tain for a long time, and drugs and surgical help are necessary
[10, 11]. There are known many legal and illegal organic
compounds which can increase metabolism [12–14]. Similar
results have also been observed for inorganic compounds,
e.g., chromium [15, 16]. One of the new possibilities is
treatment of all these diseases with vanadium compounds.
Vanadium has been investigated as a potential microelement
useful in diabetes treatment for more than 30 years [17–20].
Undesirable effects such as nausea, diarrhea, stool discolor-
ation, abdominal cramps, etc. are sometimes observed during
the treatment with vanadium compounds [21]. As the admin-
istered doses of vanadium compounds are usually high, they
can give toxic effects. The differences observed between
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positive and toxic effect are very important in determining the
therapeutic doses of the tested vanadium compounds [22–26].
At present, in the research of vanadium compounds, the mini-
mal therapeutic doses are used to minimize the toxic or side
effects. For this moment, bis(maltolato)oxovanadium(IV)
(BMOV) is frequently used as a reference substance because
the number of experiments with this chemical substance is the
highest [27–29]. Other compounds are not investigated in all
aspects as BMOV but sometimes have better properties in
selected aspects, especially small toxicity with the same thera-
peutic effect [6, 7]. Vanadium coordination compounds with
organic ligands showed lower toxic effect in comparison to
simple inorganic compounds (e.g., NaVO3 and VOSO4) and,
therefore, researches concentrate now on different organoligand
vanadium compounds [30]. Although the body mass growth
during vanadium treatment was smaller than in control vanadi-
um not treated animals, the authors of this paper are not aware
of any works concerning the influence of the tested vanadium
compounds on complete energy balance. Many researchers
believe that small body growth during the experiment was
associated with potential toxic effect or problems of gastroin-
testinal tract. Our observations and energy balance can show a
potential new action of vanadium in metabolism regulation.
Materials and Methods
Vanadium Complex
Bisperoxo complex of vanadium (V)–Na[VO(O2)2(4,4′-Me2-
2,2′-bpy)]•8H2O (MW=481.94 g/mol). The synthesis was
carried out by modified method described in literature [31].
Ten millimoles of NaVO3 was dissolved in molar excess of
10%H2O2 (molar ratio of H2O2 to vanadium is equal 1:3). To
the obtained clear yellow solution, cooled in the ice bath,
20 ml of ethanolic solution containing 10 mmol of proper
4,4′-Me2-2,2′-bpy (4,4′-dimethyl-2,2′-bipyridine) was added
dropwise with constant stirring. Temperature of the reaction
mixture did not exceed 10 °C during the synthesis.
Afterwards, 50 ml of cooled ethanol was added to precipitate
yellow crystals. The solid phase was filtered off via a glass frit
and washed with 10 ml of cold ethanol. Obtained vanadium
complex was dried in the air, in a dark place, for 24 h, then it
was collected and stored in the refrigerator. Purity of obtained
complex was confirmed by microanalysis, spectroscopic
methods: 1H NMR and IR. The structure of complex anion
is presented in Fig. 1.
Food for Animals
Animals used in the experiment had unlimited access to food
and drinking water. Three different diets were used in the
experiment: normal, high-fructose, and high-fatty. All of these
diets were prepared especially for this experiment in the
Department of Food Chemistry and Nutrition Jagiellonian
University Medical College. Table 1 below presents the used
components.
Animals
The experiment was conducted on 3-month-old male Wistar
rats, weighing 250±15 g and caged in the temperature of
23 °C, humidity 50–60 %, and light dark cycle (12/12 h).
Each group consisted of six animals. During 5 weeks of the
experiment, each group of animals was fed a different diet:
control (C), fructose (Fr), fatty (Fa), control with vanadium
(CV), fructose with vanadium (FrV), and fat with vanadium
(FaV). The diet composition is shown in Tab. 1. The animals
had unlimited access to food and water. The groups of the
animals with vanadium were treated with vanadium complex
(Na[VO(O2)2(4,4′-Me2-2,2′-bpy)]•8H2O) in the dose of
20 mg/kg one time daily (at 9 a.m.) during 5 weeks directly
to stomach by gavage. Food and water consumption were
measured three times per week (Monday, Wednesday, and
Friday) during 5 weeks of the experiment. Body mass was
also recorded at the same time. After 5 weeks of the experi-
ment, the animals were anesthetized and organs—brain, heart,
liver, testicles, kidneys, lung, spleen, and pancreas—were
isolated and immediately weighed with an accuracy to 1 mg
on the Sartorius basic scales.
Statistics
All statistical analysis was made using Statistica 10
software and nonparametric test with p<0.05 as statisti-
cal significance. In Table 2 are presented results as
median±standard deviation.
Results
(A) It was observed during the experiment that the animals in
the tested groups consumed similar quantities of food.
However, the body mass increase in various groups was
different. A decision was made to calculate the kJ/g ratio of
body mass increase, which would allow determining how the
tested diets and vanadium influenced the bodymass growth in
the tested animals. The influence was assessed based on the
quantity of kilojoules delivered in the food consumed by all
animals in a given group, divided by the aggregate body mass
increase of the animals in that group (Table 2). In the case of
vanadium nontreated animals, the lowest value of the kJ/g
ratio was observed in the fructose and fatty diets (Fr and Fa).
The body weight gain of about 1 g in the animals from the
control group (C) required statistically more kJ in comparison
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to the fructose and fatty diet. Vanadium treatment in all the
used diets caused statistically significant increase of the kJ/g
ratio in comparison to vanadium not treated animals. The
smallest differences were observed between Fr and FrV
groups. The biggest differences were observed between C
versus CVand Fa versus FaV groups.
(B) Body mass growth (Table 2) was calculated as a dif-
ference in weight of the animal at the end and at the beginning




bpy)]•8H2O) used in present
investigation
Table 1 Percentage composition
of the diets used in the experiment Component Normal diet (C) (%) High-fructose diet (Fr) (%) High-fatty diet (Ft) (%)
Starch 62.0 31.0 32.0
Casein 20.0 20.0 20.0
Rapeseed oil 5.0 5.0 5.0
Fructose 0.0 31.0 0.0
Lard 0.0 0.0 30.0
Calcium carbonate 2.8 2.8 2.8
Ca3(PO4)2 2.9 2.9 2.9
Lecithin 1.0 1.0 1.0
NaCl 0.3 0.3 0.3
Cellulose 4.7 4.7 4.7
Minerals and vitamins mix. 1.0 1.0 1.0
MgO 0.07 0.07 0.07
K2SO4 0.23 0.23 0.23
Caloric kJ/g 16.024 16.024 22.555
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of the experiment. Fructose (Fr) and fatty diet (Fa) increased
body growth in comparison to the control animals (C) in all
vanadium not treated animals but the result was not statisti-
cally significant. In the case of vanadium-treated animals,
significant difference was observed for the normal (CV) and
the fructose diet (FrV). The fatty diet (Fa) also increased body
growth in comparison with the normal diet (CV), but not
statistically. Vanadium treatment slows the growth rates of
body weight compared to the animals without vanadium
treatment.
(C) Kidney percentage in all body mass: Comparing the
obtained results (Table 2), a clear influence of diet on the kidney
mass percentage share in the total animal body mass can be
observed. Fatty diet (Fa) decreased the kidney mass percentage
in comparison to the control group but the result was not
statistically significant. In the Fr group, a statistically significant
increase of the kidney mass percentage was observed in com-
parison to the fatty diet group. No influence of the tested
vanadium compound on the tested parameter was observed.
(D) Liver percentage in all body mass: The diet influence on
the analyzed organ was observed also in the case of the liver
percentage share in the total animal body mass (Table 2). Fatty
diet (Fa) decreased—although not statistically—the liver mass
in comparison to the control group (C) and statistically in
comparison to the fructose diet group. In the vanadium-
treated animal groups, practically no differences were observed.
Additionally, vanadium influence was observed in fatty diet. In
the vanadium compound treated animals with fatty diet, statis-
tical increase of the liver mass percentage was observed.
(E) Spleen percentage in all body mass: The spleen mass
percentage in proportion to the body mass was the lowest in
the FaV group and the highest in the Fr group (Table 2).
However, no statistically significant differences were ob-
served for that parameter. One can only point to a tendency
of the indicator to decrease in case of fatty diet. Adding the
tested vanadium compound to fatty diet intensifies the indica-
tor decrease.
(F) Heart percentage in all body mass: The heart mass
percentage share in the total body mass was the highest for
the control group animals (C) and the lowest for the fatty diet
animal group (Table 2). A tendency of that indicator to
decrease was observed in all animal groups receiving the
tested vanadium compound. The differences were close to
being statistically significant for the C group in comparison
to CVand Fr in comparison to FrV.
(G) Liver steatosis in different groups of animals: In the Fa
animal group, that parameter was also insignificantly lower
(Table 2). A clear influence of the Fr and Fa diets on liver
steatosis in comparison to the control group (C) was observed
(verging on being statistically significant). Adding vanadium
to the fructose and fatty diet resulted in statistically significant
decrease of the liver steatosis.
Discussion
In the past, one of the signs of high social status was a rounded
posture. This meant that the owner did not lack food and could
protect his or her family. During the centuries, people had
many problems with the provision of adequate calories [32].
Crop failure was often the cause of famine. In addition,
average physical activity was significantly greater than at
present. The technological development of modern agriculture
has increased food surpluses [33]. The use of machines in the
course of industrial production reduced demand for physical
work. Both these factors: the availability of food and low
physical activity, are a major cause of obesity and diseases
associated with this problem [34]. In some countries, e.g.,
USA or Mexico, the percentage of obese population (BMI>
30 kg/m2) is higher than 20 % [35]. Obesity increases the risk
of hypertension, diabetes, metabolic disorders associated with
distorted lipid metabolism, and fat redistribution (abdominal
type obesity is very unfavorable) [36]. In the world, the
awareness of this risk increases and various programs are
developed to combat this threat. Deficit of energy associated
with the reduction of calorie intake plays a principal role in
lowering body mass but compliance with dietary recommen-
dations may not be possible for a lot of people for different
reasons. One of the possibilities is supplementation of prod-
ucts which increase body metabolism [10, 37]. It is of great
importance for persons more than 40 years old whose metab-
olism is slower that in young people as in this period of life
Table 2 Results for measured parameters in different group of animals (median±standard deviation)
Group Ratio energy /g













C 89.60±1.86 110.5±15.4 0.647±0.052 3.892±0.424 0.188±0.035 0.296±0.015 20.02±5.58
Fr 79.13±2.47 132.0±12.0 0.688±0.054 4.003±0.288 0.190±0.022 0.281±0.009 28.75±7.04
Fa 82.48±2.28 125.0±21.3 0.557±0.027 3.491±0.171 0.176±0.006 0.268±0.016 27.00±5.48
CV 115.98±0.56 84.5±13.3 0.645±0.049 3.786±0.278 0.175±0.022 0.278±0.011 21.06±5.94
FrV 86.88±0.44 113.0±19.4 0.731±0.036 3.850±0.241 0.177±0.008 0.270±0.005 20.59±1.41
FaV 104.68±3.01 95.0±28.2 0.623±0.050 3.655±0.110 0.161±0.016 0.270±0.012 18.67±2.39
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problems with glucose tolerance begin. For the moment, some
products are used: thermogenics such as L-carnitine [38],
chromium picolinate [15, 16], chitosan [39], or chlorogenic
acid-ACG [40], hydroxycitric acid-HCA [41], gymnemic acid
[42], which belong to amylase inhibitors which reduce the
absorption of glucose and block the formation of fat from
carbohydrates. With respect to these products, metals such as
chromium or vanadium showed interesting effects. Vanadium
and its compounds have been tested since 1980s as a potential
antidiabetic substance which can help in diabetes treatment
[17–21]. During experiments with this element, a decrease of
bodymass growwas observed in comparison to the vanadium
not treated animals. Many researches thought that this effect
was associated with toxicity of vanadium because they did not
make energetic calculation between consumed energy and
body mass growth. In our study, three different diets were
tested: control, one with 30 % of fructose and one with 30 %
of saturated animal fat (lard). During 5 weeks of the experi-
ment, clear effect of the used diets C, Fa, Fr, CV, FaV, and FrV
on the calculated ratio was observed: the number of absorbed
calories to weight gain (kJ/g). Addition of fructose or lard has
an influence on the metabolism and transformation of energy
from animal feed to body mass. The ratio calculated for
fructose was 79.13±2.47 kJ/g and it was similar to the ratio
for lard addition which was 82.48±2.28 kJ/g. For the control
feed, the ratio was 89.60±1.86 kJ/g and the result was statis-
tically significant in comparison to both diets with fructose or
fat. More interesting observations were reported on vanadium
treatment in these three diets where the calculated ratio statis-
tically increased. Vanadium evidently influenced metabolism
and the transformation of energy into body mass of the inves-
tigated animals. In control diet, the vanadium treatment in-
creased the ratio from 89.60±1.86 to 115.98±0.56 kJ/g. For
fatty diet, the ratio increased from 82.48±2.28 to 104.68±
3.01 kJ/g. The smallest—but significant—increase was ob-
served for the calculated ratio for fructose diet where vanadi-
um increased this coefficient from 79.13±2.47 to 86.88±
0.44 kJ/g. The mechanism of metabolism action was not
studied in this experiment but our observations open possibil-
ities for future investigations associated with the observed
effect. For better understanding of the possibilities into what
the energy from food was transformed (for example: increase
of protein production, body temperature, physical activation,
or other ways), it is necessary to prepare the next experiment
which can provide answers to these hypotheses. Comparing
the obtained results from our experiment with works of other
authors is also difficult because they did not make this type of
calculation. Based on the results of the work of Chung et al.
[43] and Shi et al. [44], after the ratio (kJ/g) calculation, our
results are similar to their observations. High-fat diet treatment
increases energy processing into body weight. Vanadium
treatment not only influences body mass and transformation
of energy from animal feed into body mass. Also the size of
some organs is associated with diets and vanadium. The
biggest differences are reported for the kidney and the liver,
smaller for the spleen and the heart. The percentage of kidney
weight in the whole body was the lowest in both fatty diet
groups: with vanadium treated and not treated animals. In both
fructose groups, the percentage of kidney weight in whole
body mass was the highest.
In the case of the liver, differences between groups in
vanadium not treated animals are observed. The percentage
of liver weight in the whole body mass was the smallest in the
fatty diet group and it was statistically significant in compar-
ison to the fructose group. In the vanadium-treated groups,
differences between diets were minor. It suggests that the type
of nutrition can influence mass of investigated organs. Similar
observations (relative organ mass) but for gonad or pancreas
mass and for iron were reported by Suliburska et al. [45, 46].
Liver steatosis was also analyzed in the tested animals.
Fructose and fat diet statistically increased fat in the liver in
comparison to the control group. These results were similar to
observations of other authors: high-fructose diet [44, 47] and
high-fat diet [48, 49]. Vanadium administration in fructose and
fat diets lowered the fatty liver to the level characteristic to the
control group (without additions of fructose, fat, or
vanadium).
This suggests that vanadium may influence fat metabolism
in the liver. Unfortunately for this moment, there are no other
author works describing similar experiments. Accumulation
of fat in the liver tissue may result in increased levels of liver
enzymes which in consequence may be the cause of insulin
resistance and glucose intolerance as a result of oversupply of
fatty acids. This is a hypothesis because the share of fatty liver
in the formation of insulin resistance is not fully understood.
On the other hand, vanadium activity manifested in the de-
crease of liver steatosis is associated with their antidiabetic
activity.
In the case of the spleen and the heart, we can speak only of
tendencies. Fatty diet decreases the percentage of spleen
weight in the whole body in both vanadium-treated and not
treated rats. To better understand the interrelationships, it is
necessary to determine the total body fat and muscles tissues.
The increase of fat tissue usually results in the growth of body
mass and in the decrease of percentage of the investigated
organ mass in the whole body mass. In this study, animals
were in the growth phase and the observed changes can be
also associated with growth not related to fat tissue increase in
the total body mass.
Vanadium treatment also influences the percentage of heart
weight in all body mass where only tendencies are observed
but not significant. Perhaps, a study with a bigger number of
animals can show significant differences.
The reported observations for fructose and fat diet are
reported by other authors. High processed food, easily assim-
ilated sugars, excess fat (especially saturated), and little
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physical activity cause obesity development and are among
the most important factors of civilization diseases. One of
potential methods to fight this problem may be the use of
vanadium compounds. Type 2 diabetes is frequently associat-
ed with insulin resistance caused by obesity. This problem is
currently more and more visible in lifestyle diseases. For the
moment, to achieve body mass reduction, the smallest nutri-
tion portions and special diets are recommended. Frequently,
this method in the longer term not only does not produce clear
results but also produces the yo-yo effect. Investigation of
substances which limit the utilization of energy from food and
also normalize the glucose level, e.g., tested by us vanadium
compound, will be very helpful in diabetes treatment.
Conclusion
Vanadium methyl-bipyridine organoligand increase food and
energy consumption necessary for body mass growth.
Fructose and fat diet encourages faster weight gain relative
to the control diet.
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